Articles by Daniel Marsh
Shenzhen ChiNext Reforms Unveiled Amid Weekly Market Declines
Chinese regulators announced updated listing standards for Shenzhen's ChiNext board to attract innovative firms, yet major indices posted weekly losses. The Shenzhen Component dropped 2.2%, while the Shanghai Composite declined 0.9%.
GlobalData Upgrades to LSE Main Market as MiniMax, Cinemark Show Divergent Paths
GlobalData Plc has moved to the London Stock Exchange's Main Market, marking a strategic milestone. Meanwhile, MiniMax Group shares rally on AI optimism despite financial concerns, and Cinemark Holdings appears undervalued amid strong momentum.
MakeMyTrip Acquires Majority Stake in Regional Tour Operator Flamingo
MakeMyTrip has agreed to acquire a controlling interest in regional tour operator Flamingo Transworld, strengthening its position in the growing holiday packages segment. The deal comes as the company's hotel and packages revenue rose 9.7% last quarter.
Cintas Nears $5.2B Acquisition of UniFirst at $275/Share Premium
Cintas is reportedly close to finalizing a $5.2 billion acquisition of UniFirst at over $275 per share, representing a 64% premium. UniFirst shares surged 13.6% in premarket trading following the report.
Nu Holdings Secures Inter Miami Stadium Naming Rights in U.S. Expansion Drive
Nu Holdings Ltd. has acquired naming rights for Inter Miami CF's new 26,700-seat stadium, now called Nu Stadium, as the Brazilian fintech seeks to expand its U.S. presence. The multiyear deal includes jersey branding starting in August.
Tesla's UK Market Share Slips as BYD Gains Ground
Tesla's UK registrations dropped sharply in February, down 37.1% to 2,422 vehicles, even as the broader new-car market grew. BYD's registrations soared 83% to 2,154, nearly matching Tesla's volume.
Wall Street Outperforms Global Markets Amid Iran Conflict, Oil Surge
U.S. equity futures edged lower Friday as geopolitical tensions with Iran fueled oil prices and inflation concerns, though Wall Street is set to outperform global peers this week. The Nasdaq remains on track for a modest weekly advance.
Bradesco Consolidates Health Assets into $52B Bradsaúde Ahead of March Vote
Banco Bradesco will combine its health and dental assets into a new publicly traded entity named Bradsaúde, targeting R$52 billion in 2025 revenue. The proposal requires shareholder approval on March 31.
Zealand Pharma Stock Crashes on Obesity Drug Data Lagging Lilly
Zealand Pharma A/S shares plunged over 32% Friday after mid-stage trial results for its obesity drug candidate petrelintide showed weight loss well behind Eli Lilly's competing therapy, erasing billions in market value.
Compass Group Defies FTSE Slump as 2026 Targets Steady AI Concerns
Compass Group PLC shares climbed 3.18% to 2,306 pence on Thursday, outperforming a declining FTSE 100. The global caterer reaffirmed its 2026 outlook for approximately 7% organic revenue growth and 10% underlying operating profit expansion.
HSBC Executive's Major Share Sale Sparks Capital Strategy Scrutiny
HSBC's Asia and Middle East co-CEO sold HK$43.2 million in shares, coinciding with the bank's decision to pause buybacks until its capital ratio recovers. The bank reported 2025 pretax profit fell 7% to $29.9 billion.
Hindustan Unilever Sells Nutritionalab Stake, Sharpens Focus on Premium Brands
Hindustan Unilever has divested its entire 19.8% holding in Nutritionalab Private Limited for approximately 3.07 billion rupees. The move aligns with a broader strategy to concentrate investment on high-growth premium categories.